ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 310 filers reported holding ISHARES TR in Q4 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,525 | -5.0% | 7,154 | -3.1% | 0.03% | -6.9% |
| Q2 2023 | $745,519 | -13.1% | 7,386 | -12.4% | 0.03% | -17.1% |
| Q1 2023 | $857,678 | +0.2% | 8,428 | +2.6% | 0.04% | -18.6% |
| Q4 2022 | $856,362 | +45.1% | 8,215 | +27.3% | 0.04% | +38.7% |
| Q3 2022 | $590,000 | +1.7% | 6,453 | +11.9% | 0.03% | +3.3% |
| Q2 2022 | $580,000 | -2.4% | 5,765 | +3.9% | 0.03% | +20.0% |
| Q1 2022 | $594,000 | +6.5% | 5,547 | +0.4% | 0.02% | +4.2% |
| Q4 2021 | $558,000 | +10.3% | 5,524 | +3.2% | 0.02% | -4.0% |
| Q3 2021 | $506,000 | +36.8% | 5,355 | +39.7% | 0.02% | +31.6% |
| Q2 2021 | $370,000 | +2.5% | 3,832 | +0.7% | 0.02% | -9.5% |
| Q1 2021 | $361,000 | +4.9% | 3,805 | -2.8% | 0.02% | -12.5% |
| Q4 2020 | $344,000 | +10.6% | 3,914 | +1.5% | 0.02% | -79.8% |
| Q3 2020 | $311,000 | -14.3% | 3,858 | -13.7% | 0.12% | +271.9% |
| Q2 2020 | $363,000 | +12.0% | 4,470 | -1.1% | 0.03% | -5.9% |
| Q1 2020 | $324,000 | -43.4% | 4,522 | -22.4% | 0.03% | -22.7% |
| Q4 2019 | $572,000 | +40.9% | 5,828 | +35.0% | 0.04% | +4.8% |
| Q3 2019 | $406,000 | +15.0% | 4,317 | +15.7% | 0.04% | +5.0% |
| Q2 2019 | $353,000 | +5.4% | 3,732 | +5.5% | 0.04% | -63.6% |
| Q1 2019 | $335,000 | +8.1% | 3,539 | -3.7% | 0.11% | +74.6% |
| Q4 2018 | $310,000 | -51.7% | 3,676 | -50.9% | 0.06% | -47.5% |
| Q3 2018 | $642,000 | -12.5% | 7,481 | -13.3% | 0.12% | +21.2% |
| Q2 2018 | $734,000 | -43.0% | 8,628 | -43.4% | 0.10% | -45.0% |
| Q1 2018 | $1,288,000 | +259.8% | 15,246 | +284.6% | 0.18% | +227.3% |
| Q4 2017 | $358,000 | +10.8% | 3,964 | +5.6% | 0.06% | +12.2% |
| Q3 2017 | $323,000 | +2.9% | 3,753 | -1.0% | 0.05% | -2.0% |
| Q2 2017 | $314,000 | +18.0% | 3,789 | +19.6% | 0.05% | +4.2% |
| Q1 2017 | $266,000 | +6.8% | 3,167 | +5.0% | 0.05% | -2.0% |
| Q4 2016 | $249,000 | -7.8% | 3,017 | -9.0% | 0.05% | -9.3% |
| Q3 2016 | $270,000 | +8.9% | 3,317 | +9.8% | 0.05% | +5.9% |
| Q2 2016 | $248,000 | – | 3,022 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
| Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
| Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
| Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
| VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
| SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
| Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
| Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
| MCIA Inc | 182,506 | $18,400,000 | 9.20% |
| Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |